title: Morphoea (localized scleroderma): baseline body surface involvement and antinuclear antibody may have a prognostic value.
authors.forename: E
authors.initials: E
authors.lastname: Alimova
authors.forename: D
authors.initials: D
authors.lastname: Farhi
authors.forename: F
authors.initials: F
authors.lastname: Plantier
authors.forename: A
authors.initials: A
authors.lastname: Carlotti
authors.forename: I
authors.initials: I
authors.lastname: Gorin
authors.forename: L
authors.initials: L
authors.lastname: Mouthon
authors.forename: N
authors.initials: N
authors.lastname: Franck
authors.forename: M-F
authors.initials: MF
authors.lastname: Avril
authors.forename: N
authors.initials: N
authors.lastname: Dupin
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012594:Scleroderma, Localized / Q000175:diagnosis*; D055815:Young Adult
chemical_list: D000974:Antibodies, Antinuclear; D015415:Biomarkers